Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6). GERCOR. (Q33331373)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6). GERCOR.	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10658524

retrieved

25 July 2017

title

Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6). GERCOR. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10658524

retrieved

25 July 2017

main subject

colorectal cancer

1 reference

based on heuristic

inferred from title

oxaliplatin

1 reference

based on heuristic

inferred from title

metastatic colon cancer

1 reference

based on heuristic

inferred from title

colorectal carcinoma

1 reference

based on heuristic

inferred from title

fluorouracil

1 reference

based on heuristic

inferred from title

author name string

Maindrault-Goebel F

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10658524

retrieved

25 July 2017

Louvet C

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10658524

retrieved

25 July 2017

André T

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10658524

retrieved

25 July 2017

Carola E

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10658524

retrieved

25 July 2017

Lotz JP

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10658524

retrieved

25 July 2017

Molitor JL

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10658524

retrieved

25 July 2017

Garcia ML

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10658524

retrieved

25 July 2017

Gilles-Amar V

series ordinal

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10658524

retrieved

25 July 2017

Izrael V

series ordinal

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10658524

retrieved

25 July 2017

Krulik M

series ordinal

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10658524

retrieved

25 July 2017

de Gramont A

series ordinal

11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10658524

retrieved

25 July 2017

publication date

1 September 1999

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10658524

retrieved

25 July 2017

published in

European Journal of Cancer

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10658524

retrieved

25 July 2017

volume

35

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10658524

retrieved

25 July 2017

issue

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10658524

retrieved

25 July 2017

page(s)

1338-1342

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10658524

retrieved

25 July 2017

cites work

Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900149-5

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

A chronopharmacologic phase II clinical trial with 5-fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic colorectal cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900149-5

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

A review of GERCOD trials of bimonthly leucovorin plus 5-fluorouracil 48-h continuous infusion in advanced colorectal cancer: evolution of a regimen. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD)

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900149-5

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900149-5

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Bimonthly high-dose leucovorin, 5-fluorouracil infusion and oxaliplatin (FOLFOX3) for metastatic colorectal cancer resistant to the same leucovorin and 5-fluorouracil regimen.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900149-5

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900149-5

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Activity of continuous-infusion 5-fluorouracil in patients with advanced colorectal cancer clinically resistant to bolus 5-fluorouracil.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900149-5

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900149-5

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900149-5

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. International Organization for Cancer Chronotherapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900149-5

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1016/S0959-8049(99)00149-5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10658524

retrieved

25 July 2017

PubMed publication ID

10658524

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10658524

retrieved

25 July 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33331373&oldid=1948519475"